Conversely, low GSH levels have been associated with NAFLD in humans [13], suggesting that the factors promoting steatosis (i.e., elevated Ang II, impaired lipid metabolism, impaired hepatic glycolysis, etc.)chronically may also compromise the liver. Here, AGT is linked to metabolic dysfunction-associated steatotic liver disease.